Ovarian Cancer Trial, Recruiting (NCT06232122)

Ovarian Cancer Trial, Recruiting NCT06232122 Sponsor: Chang Gung Memorial Hospital Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06232122 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with ovarian cancer (confirmed by a laboratory/tissue test) and have had a complete response to treatment, meaning your cancer appeared to go away after therapy
You are between 30 and 80 years old
Your blood test shows a specific cancer marker called CA125 is either above the normal level (above 35 U/mL) or has doubled, even if still within the normal range
You are generally healthy and able to carry out light daily activities (as assessed by your doctor), and you are willing to receive further treatment if your cancer is found to have come back
You are willing to take part in this research study and sign a consent form agreeing to participate

Who may not be able to join:

You have a history of any other type of cancer
You are currently pregnant or breastfeeding
Your fasting blood sugar level is higher than 200 mg/dl (measured by a fingertip blood test after not eating)
You have had a known allergic reaction to the special imaging substances used in the scans involved in this trial (called 68Ga-FAPI-46 or 18F-FDG)
You are unable to lie still for at least 30 minutes during the PET/CT scan, as determined by the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0975365782

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06232122

Sponsor: Chang Gung Memorial Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: 0975365782

More information: https://clinicaltrials.gov/study/NCT06232122

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with ovarian cancer (confirmed by a laboratory/tissue test) and have had a complete response to treatment, meaning your cancer appeared to go away after therapy
You are between 30 and 80 years old
Your blood test shows a specific cancer marker called CA125 is either above the normal level (above 35 U/mL) or has doubled, even if still within the normal range
You are generally healthy and able to carry out light daily activities (as assessed by your doctor), and you are willing to receive further treatment if your cancer is found to have come back
You are willing to take part in this research study and sign a consent form agreeing to participate

Who may not be able to join:

You have a history of any other type of cancer
You are currently pregnant or breastfeeding
Your fasting blood sugar level is higher than 200 mg/dl (measured by a fingertip blood test after not eating)
You have had a known allergic reaction to the special imaging substances used in the scans involved in this trial (called 68Ga-FAPI-46 or 18F-FDG)
You are unable to lie still for at least 30 minutes during the PET/CT scan, as determined by the research team

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chang Gung Memorial Hospital

Registry

ClinicalTrials.gov

Start date

1 August 2022

Est. completion

31 July 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Diagnostic performances of 68Ga-FAPI and 18F-FDG PET/CT for ovarian cancer recurrence after one year from PET/CT imaging in Per-Protocol Analysis Dataset

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov